James Gurney1,2, Léa Pradier3, Joanne S Griffin4, Claire Gougat-Barbera5, Benjamin K Chan6, Paul E Turner6,7, Oliver Kaltz5, Michael E Hochberg5,8. 1. School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA. 2. Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, GA 30332, USA. 3. CEFE/CNRS, Université de Montpellier Campus du CNRS, 1919, route de Mende, Montpellier 34293, France. 4. Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 7ZB, UK. 5. Institute of Evolution Sciences of Montpellier, Université de Montpellier, CNRS, IRD EPHE, Montpellier, France. 6. Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06511, USA. 7. Department is Program in Microbiology, Program in Microbiology, Yale School of Medicine, New Haven, CT 06510, USA. 8. Santa Fe Institute, Santa Fe, NM 87501, USA.
Abstract
BACKGROUND AND OBJECTIVES: Antimicrobial resistance is a growing global concern and has spurred increasing efforts to find alternative therapeutics. Bacteriophage therapy has seen near constant use in Eastern Europe since its discovery over a century ago. One promising approach is to use phages that not only reduce bacterial pathogen loads but also select for phage resistance mechanisms that trade-off with antibiotic resistance-so called 'phage steering'. METHODOLOGY: Recent work has shown that the phage OMKO1 can interact with efflux pumps and in so doing select for both phage resistance and antibiotic sensitivity of the pathogenic bacterium Pseudomonas aeruginosa. We tested the robustness of this approach to three different antibiotics in vitro (tetracycline, erythromycin and ciprofloxacin) and one in vivo (erythromycin). RESULTS: We show that in vitro OMKO1 can reduce antibiotic resistance of P. aeruginosa (Washington PAO1) even in the presence of antibiotics, an effect still detectable after ca.70 bacterial generations in continuous culture with phage. Our in vivo experiment showed that phage both increased the survival times of wax moth larvae (Galleria mellonella) and increased bacterial sensitivity to erythromycin. This increased antibiotic sensitivity occurred both in lines with and without the antibiotic. CONCLUSIONS AND IMPLICATIONS: Our study supports a trade-off between antibiotic resistance and phage sensitivity. This trade-off was maintained over co-evolutionary time scales even under combined phage and antibiotic pressure. Similarly, OMKO1 maintained this trade-off in vivo, again under dual phage/antibiotic pressure. Our findings have implications for the future clinical use of steering in phage therapies. Lay Summary: Given the rise of antibiotic-resistant bacterial infection, new approaches to treatment are urgently needed. Bacteriophages (phages) are bacterial viruses. The use of such viruses to treat infections has been in near-continuous use in several countries since the early 1900s. Recent developments have shown that these viruses are not only effective against routine infections but can also target antibiotic resistant bacteria in a novel, unexpected way. Similar to other lytic phages, these so-called 'steering phages' kill the majority of bacteria directly. However, steering phages also leave behind bacterial variants that resist the phages, but are now sensitive to antibiotics. Treatment combinations of these phages and antibiotics can now be used to greater effect than either one independently. We evaluated the impact of steering using phage OMKO1 and a panel of three antibiotics on Pseudomonas aeruginosa, an important pathogen in hospital settings and in people with cystic fibrosis. Our findings indicate that OMKO1, either alone or in combination with antibiotics, maintains antibiotic sensitivity both in vitro and in vivo, giving hope that phage steering will be an effective treatment option against antibiotic-resistant bacteria.
BACKGROUND AND OBJECTIVES: Antimicrobial resistance is a growing global concern and has spurred increasing efforts to find alternative therapeutics. Bacteriophage therapy has seen near constant use in Eastern Europe since its discovery over a century ago. One promising approach is to use phages that not only reduce bacterial pathogen loads but also select for phage resistance mechanisms that trade-off with antibiotic resistance-so called 'phage steering'. METHODOLOGY: Recent work has shown that the phage OMKO1 can interact with efflux pumps and in so doing select for both phage resistance and antibiotic sensitivity of the pathogenic bacterium Pseudomonas aeruginosa. We tested the robustness of this approach to three different antibiotics in vitro (tetracycline, erythromycin and ciprofloxacin) and one in vivo (erythromycin). RESULTS: We show that in vitro OMKO1 can reduce antibiotic resistance of P. aeruginosa (Washington PAO1) even in the presence of antibiotics, an effect still detectable after ca.70 bacterial generations in continuous culture with phage. Our in vivo experiment showed that phage both increased the survival times of wax moth larvae (Galleria mellonella) and increased bacterial sensitivity to erythromycin. This increased antibiotic sensitivity occurred both in lines with and without the antibiotic. CONCLUSIONS AND IMPLICATIONS: Our study supports a trade-off between antibiotic resistance and phage sensitivity. This trade-off was maintained over co-evolutionary time scales even under combined phage and antibiotic pressure. Similarly, OMKO1 maintained this trade-off in vivo, again under dual phage/antibiotic pressure. Our findings have implications for the future clinical use of steering in phage therapies. Lay Summary: Given the rise of antibiotic-resistant bacterial infection, new approaches to treatment are urgently needed. Bacteriophages (phages) are bacterial viruses. The use of such viruses to treat infections has been in near-continuous use in several countries since the early 1900s. Recent developments have shown that these viruses are not only effective against routine infections but can also target antibiotic resistant bacteria in a novel, unexpected way. Similar to other lytic phages, these so-called 'steering phages' kill the majority of bacteria directly. However, steering phages also leave behind bacterial variants that resist the phages, but are now sensitive to antibiotics. Treatment combinations of these phages and antibiotics can now be used to greater effect than either one independently. We evaluated the impact of steering using phage OMKO1 and a panel of three antibiotics on Pseudomonas aeruginosa, an important pathogen in hospital settings and in people with cystic fibrosis. Our findings indicate that OMKO1, either alone or in combination with antibiotics, maintains antibiotic sensitivity both in vitro and in vivo, giving hope that phage steering will be an effective treatment option against antibiotic-resistant bacteria.
Authors: Clara Torres-Barceló; James Gurney; Claire Gougat-Barberá; Marie Vasse; Michael E Hochberg Journal: FEMS Microbiol Ecol Date: 2018-08-01 Impact factor: 4.194
Authors: Alita R Burmeister; Abigail Fortier; Carli Roush; Adam J Lessing; Rose G Bender; Roxanna Barahman; Raeven Grant; Benjamin K Chan; Paul E Turner Journal: Proc Natl Acad Sci U S A Date: 2020-05-18 Impact factor: 11.205
Authors: Nitasha D Menon; Samuel Penziner; Elizabeth T Montaño; Raymond Zurich; David T Pride; Bipin G Nair; Geetha B Kumar; Victor Nizet Journal: Antimicrob Agents Chemother Date: 2022-07-06 Impact factor: 5.938
Authors: Sarshad Koderi Valappil; Prateek Shetty; Zoltán Deim; Gabriella Terhes; Edit Urbán; Sándor Váczi; Roland Patai; Tamás Polgár; Botond Zsombor Pertics; György Schneider; Tamás Kovács; Gábor Rákhely Journal: Front Microbiol Date: 2021-12-02 Impact factor: 5.640
Authors: Olivia Williams Barber; Iria Mañas Miramontes; Manu Jain; Egon A Ozer; Erica M Hartmann Journal: mSystems Date: 2021-07-20 Impact factor: 6.496